ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

Adding Avastin Did Not Improve Standard Chemotherapy Regimen

April 27, 2012

In Brief: DeVita Says He’ll Go Along With Any NCAB Decision On Organ Site Program; Talbt New AACI President

February 26, 1982

HCFA Abadons Plan To Cut Cancer Drug Payments.

September 15, 2000

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

November 23, 2005

Funding Opportunities

December 13, 2002